Takeda is committed to developing oncology medicines in three strategic areas of focus: hematologic, thoracic and gastrointestinal cancers. Further presentations at ESMO 2026 will highlight clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results